Form 4 for DNA Ginkgo Bioworks Holdings, Inc.
Accepted 2022-12-15 00:00:00 ET · period of report 2022-12-13 · accession 0001127602-22-027580 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-12-15 | 2022-12-13+ | DNA | Kelly Jason R | See remarks, Dir | S - Sale | $1.79 | -201.3K | 19.21M | -1% | -$359.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-12-13 | S | D | 98,934 | $1.89 | 19,316,134 | D | — | — | |
| 2 | Common | Class A Common Stock | 2022-12-14 | S | D | 102,345 | $1.69 | 19,213,789 | D | — | — |